Related Experiment Video

Updated: Oct 9, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K

Comorbidities and mortality in COVID-19 patients

Irawaty Djaharuddin1, Sitti Munawwarah1, Asvin Nurulita2

  • 1Department of Pulmonology & Respiratory Medicine, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia.

Gaceta Sanitaria
|December 21, 2021
PubMed

Insights

Comorbidities like hypertension, cardiovascular disease, and diabetes significantly increase COVID-19 mortality risk. Over half of deceased patients had multiple underlying health conditions, highlighting the need for targeted interventions.

Area of Science:

  • Medical Research
  • Epidemiology
  • Public Health

Background:

  • High mortality in Coronavirus Disease (COVID-19) patients is linked to comorbid conditions.
  • Identifying risk factors for poor COVID-19 outcomes is crucial.
  • This study aimed to identify comorbidities in patients who died from COVID-19.

Purpose of the Study:

  • To determine the prevalence of comorbidities in COVID-19 patients who died.
  • To analyze the relationship between specific comorbidities and COVID-19 mortality.
  • To assess the impact of multiple comorbidities on COVID-19 outcomes.

Main Methods:

  • Retrospective descriptive study design.
  • Inclusion of hospitalized COVID-19 patients from March to September 2020.
  • Data collection on patient demographics, comorbidities, and mortality.

Main Results:

  • Out of 454 patients, 78 (17.18%) died from COVID-19.
  • The most prevalent comorbidities in deceased patients were hypertension (42.31%), cardiovascular disease (30.77%), and diabetes (28.21%).
  • Over half of the deceased patients (52.56%) had two or more comorbidities.

Conclusions:

  • Hypertension, cardiovascular disease, and diabetes are the most frequent comorbidities associated with COVID-19 mortality.
  • The presence of multiple comorbidities significantly impacts the outcome of COVID-19 patients.
  • These findings underscore the importance of managing comorbidities in COVID-19 patient care.
Abstract

Keywords:
COVID-19ComorbiditiesMortality

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-208:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
678
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
520
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
919
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
76
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
63